Pfizer Inc on Monday announced that it would merge its off-patent drug business with generic drugmaker Mylan NV to create a global leader in low-cost treatment, a business that faces significant political pressure in the US.
The new entity, which is to be renamed upon the deal’s closure, would have a portfolio that includes impotence drug Viagra, cholesterol pills Lipitor, painkiller Lyrica and the life-saving EpiPen treatment for severe allergic reactions.
The merger comes amid rising competition in generic drugs from companies in India and elsewhere, a segment of pharma that is known for having low barriers to entry and commodity-like products.
Photo: AFP
Joining forces with Pfizer’s off-patent division, called Upjohn, would give Mylan access to more international markets.
The deal is also expected to result in US$1 billion in annual cost savings starting in 2023, the companies said.
“The combined organization will have a presence across nearly every continent and major market, establishing a new leadership position in Asia, and offering products capable of treating all major therapeutic areas,” said Mylan chairman Robert Coury, who is to serve as executive chairman of the new company.
This marks the latest move by Pfizer, which has grown into one of the world’s biggest pharma companies through a string of acquisitions.
The new company will be 57 percent owned by Pfizer shareholders and 43 percent owned by Mylan investors.
Upjohn president Michael Goettler is to serve as CEO of the new firm, while Mylan CEO Heather Bresch is to leave the company.
Pfizer, meanwhile, has announced deals in recent months to combine its consumer healthcare business with GlaxoSmithKline PLC’s unit, and to spend US$11.4 billion to acquire Array BioPharma Inc, which is known for drugs in development focused on oncology and rare disease.
Pfizer chief executive Albert Bourla said the deal with Mylan would sharpen the company’s focus on “breakthroughs that change patients’ lives.”
Separately, Pfizer reported that second-quarter profit jumped 30.3 percent to US$5 billion, due in part to a large one-time boosts from a favorable US tax settlement and a lower tax rate after the late 2017 US tax cut signed by US President Donald Trump.
Revenues dropped 1.5 percent to US$13.3 billion.
Pfizer also cut some of its financial forecasts for this year, citing the accounting of the GlaxoSmithKline and Array transactions.
Mylan’s share price surged 12.6 percent to end the day at US$20.78, while Pfizer fell 3.8 percent to US$41.45.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day